A new study in Finland has revealed that inherited malignant ventricular arrhythmia is fairly common among Finnish Leonbergers under three years of age. At its worst, such arrhythmia can result in the dog’s sudden death.
Read More

Texans who are college-educated, live in suburban or urban areas, have higher median incomes and are ethnically white are less likely to vaccinate their children, according to analysis by researchers at The University of Texas at Austin. The findings could help public health officials identify pockets of low vaccination rates where communities within the state are at higher risk for an outbreak of vaccine-preventable diseases such as measles.
Read More

Pancreatic cancer is predicted to become the second leading cause of cancer-related deaths by 2030. However, recent developments in staging and treatment provide options to improve the long-term survival rate for an otherwise devastating diagnosis.
Read More

An Apple employee at the tech giant’s European headquarters in the city of Cork has tested positive for the novel coronavirus, the firm said Tuesday.
Read More

Austria and Slovenia announced Tuesday they would severely restrict travel from neighbouring Italy, the country worst hit by the new coronavirus after China.
Read More

Italians faced travel restrictions inside and outside the country Tuesday as nations near and far isolated Italy with flight bans and sweeping national measures went into effect in a bid to slow the coronavirus’ silent spread across the peninsula.
Read More

Italy recorded 168 deaths Tuesday from the novel coronavirus, its highest single-day toll to date, pushing the number of fatalities outside China to more than 1,000.
Read More

Adam Castillejo was known until recently only as the “London patient.” Now, after surviving years of grueling treatments, he says he sees himself as an “ambassador of hope” for others.

Read More

EU leaders held emergency talks by videoconference Tuesday as they scrambled to coordinate a Europe-wide response to the coronavirus epidemic, which has roiled markets and put Italy on lockdown.
Read More

The study authors said that their analysis found that an expensive new branded formulation of PrEP — touted as being safer by the company that makes  it — would in reality be no better than cheaper generics.

Read More